These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3569134)

  • 1. Comparative studies on estrogen receptors between a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous tumors.
    Matsuzawa A; Hayakawa T; Takitani S; Iwaguchi T
    Endocrinology; 1987 Jun; 120(6):2346-56. PubMed ID: 3569134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic estrogen receptor in a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous lines.
    Matsuzawa A; Mizuno Y; Yamamoto T; Hori T; Suzuki T
    Cancer Res; 1980 Sep; 40(9):3361-8. PubMed ID: 7427949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated progression to autonomy of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by hormones.
    Matsuzawa A; Kaneko T; Ikeda Y
    Cancer Res; 1983 May; 43(5):2283-9. PubMed ID: 6831452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin regulation of estrogen and progesterone receptors in normal and neoplastic mouse mammary tissue.
    Koseki Y; Cole D; Matsuzawa A; Costlow ME
    Jpn J Cancer Res; 1987 Oct; 78(10):1105-11. PubMed ID: 3119544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression from hormone dependence to autonomy and angiogenesis in mouse mammary tumours.
    Oikawa T; Matsuzawa A; Iwaguchi T
    Br J Cancer; 1986 Jul; 54(1):91-6. PubMed ID: 2425838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in metallothionein expression in transplantable mouse mammary tumor lines.
    Yamamura Y; Sayama K; Takeda Y; Matsuzawa A; Iguchi T; Ohta Y
    Cancer Lett; 1999 Apr; 138(1-2):167-74. PubMed ID: 10378789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of repeated exposure to cyclophosphamide on drug resistance and biological properties of a newly autonomy-acquired mouse mammary tumor (T4-OI320).
    Takeda Y; Matsuzawa A; Kaneko T; Sekiguchi M; Fujii G
    Jpn J Exp Med; 1988 Apr; 58(2):87-98. PubMed ID: 2842525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential response of an ovarian-responsive mouse mammary tumor to androgenic and estrogenic agents.
    Matsuzawa A; Ikeda Y
    Cancer Res; 1983 Aug; 43(8):3680-6. PubMed ID: 6861137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of duct-alveolar structures and new types of tumors by a pregnancy-dependent mouse mammary tumor (TPDMT-4) in virgin mice.
    Matsuzawa A; Kaneko T; Ikeda Y; Yamamoto T
    Gan; 1982 Jun; 73(3):372-6. PubMed ID: 7129002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of basal cell phenotype with acquisition of lung-colonizing capability in mouse mammary tumors.
    Tsubura A; Inui T; Morii S; Dairkee SH; Oikawa T; Matsuzawa A
    Breast Cancer Res Treat; 1991; 17(3):239-43. PubMed ID: 1710155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of estrogen and progesterone receptor levels in mouse mammary epithelial cells grown in serum-free collagen gel cultures.
    Edery M; Imagawa W; Larson L; Nandi S
    Endocrinology; 1985 Jan; 116(1):105-12. PubMed ID: 2981060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin mediation of estrogen-induced changes in mammary tissue estrogen and progesterone receptors.
    Muldoon TG
    Endocrinology; 1987 Jul; 121(1):141-9. PubMed ID: 3595517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere length, telomerase activity and telomerase RNA expression during mouse mammary tumor progression.
    Kiyozuka Y; Asai A; Senzaki H; Uemura Y; Nakashima A; Morimoto J; Matsuzawa A; Tsubura A
    Int J Mol Med; 1998 Oct; 2(4):437-44. PubMed ID: 9857231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of pregnancy-dependent mouse mammary tumors after long dormancy periods. Involvement of Wnt pathway activation.
    Gattelli A; Cirio MC; Quaglino A; Schere-Levy C; Martinez N; Binaghi M; Meiss RP; Castilla LH; Kordon EC
    Cancer Res; 2004 Aug; 64(15):5193-9. PubMed ID: 15289324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metallothionein expression in transplantable mouse mammary tumors.
    Yamamura Y; Sayama K; Takeda Y; Matsuzawa A; Iguchi T; Ohta Y
    Anticancer Res; 2000; 20(1A):379-84. PubMed ID: 10769683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues in vitro.
    Klinge CM; Bambara RA; Zain S; Hilf R
    Cancer Res; 1987 Jun; 47(11):2852-9. PubMed ID: 3105869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of progesterone receptors, estrogen receptors, and estrogen (type II)-binding sites in the hormone-independent variant of the MXT-3590 mouse mammary tumor.
    Watson CS; Medina D; Clark JH
    Endocrinology; 1980 Nov; 107(5):1432-7. PubMed ID: 7428677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular existence of estrogen receptor in C3H mouse mammary tumor.
    Fujimoto J; Tamaya T; Watanabe Y; Arahori K; Okada H
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):773-7. PubMed ID: 3722957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of estradiol and estriol with uterine estrogen receptor in vivo and in excised uteri or cell suspensions at 37 C: noncooperative estradiol binding and absence of estriol inhibition of estradiol-induced receptor activation and transformation.
    Müller RE; Traish AM; Wotiz HH
    Endocrinology; 1985 Nov; 117(5):1839-47. PubMed ID: 4042965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the estradiol-mediated endometrial gland formation by the antigestagen onapristone in rabbits: relationship to uterine estrogen receptors.
    Chwalisz K; Hegele-Hartung C; Fritzemeier KH; Beier HM; Elger W
    Endocrinology; 1991 Jul; 129(1):312-22. PubMed ID: 2055191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.